Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Phase II Study of Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome (ARDS) After Thoracic Surgery (E-START)

NCT00290602 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT00290602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00290602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Phase II Study of Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome (ARDS) After Thoracic Surgery (E-START)
Lead sponsor
National Cancer Center, Korea
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2004
Completion date
December 31, 2006
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lung injury, acute respiratory distress syndrome, postoperative complications